BREAKING—Sydney 🇦🇺 just announced a two week lockdown for Greater Sydney because of #DeltaVariant. “If we’re going to do this, we need to do it properly. There’s no point doing a 3-day and then having #COVID19 continue to bubble away in the community.” theguardian.com/australia-news…
2) “at this stage, the best health advice we have is that a 2-week period or until midnight on Friday, July 9, is necessary, in order to make sure that we get to our target of zero community transmission, which has always been our target from the beginning of the pandemic.
3) “Given how transmissible the virus is, given extra exposure venues, we know that even the best contact tracers in the world can’t stay a step ahead unless we put this in and we need to do it properly. So there was no point doing 3-5 days because it wouldn’t have done the job.
4) “The best health advice today is that it should be for two weeks, but if there is any massive improvement ahead of that time, of course, we’ll evaluate that. But the best advice we have from Dr Chant and the health experts is that we should brace ourselves for more cases”
5) “We’re finding that all household contacts, unfortunately, are getting the virus. Transmissibility is at least double what previous variants had been. So we do need to brace ourselves for potentially larger number of cases in the following days”
6) Asked about the timing of announcing this lockdown, she went on to say:
“Just in the last couple of hours, we were advised that potentially there are a couple of cases that have been active in the community outside of the areas of concern for a few days.”
7) Chief health officer Kerry Chant is asked what to do if you’re a resident of one of the locked down areas but have already left the lock down zone for a holiday recently?
She clarifies: …
8) “Those individuals if they’ve been in Greater Sydney since June 21 will need to follow the stay-at-home orders for that period for 14 days since they left.
They can buy food and groceries and enjoy the outdoor environment, but they can’t go to hospitality and other venues.”
9) How the hell did Sydney let #COVID19 explode after controlling it so well last year? #DeltaVariant of course — and its incredibly fast transmission where just seconds of “fleeting” exposure enough to infect someone. And oh boy did the airport limo driver did… see 🧵…
10) “they just passed each other in the store”… “there was no contact”. #DeltaVariant is just that contagious and fleeting. Please #MaskUp
11) One of the other “fleeting” contacts was with another woman in an outdoors cafe. Yes you heard that right. And they were sure she got it from him because of the genomic exact match of the virus.
12) #DeltaVariant is extremely fast. It is the fastest transmitting variant known to date. The WHO data from 64 countries shows it is leaps and bounds faster than all previous major variants of concern
13) Sydney has to do a lockdown because its vaccination rate is abysmally low due to low vaccine supply. Australia vaccination rate is roughly India’s… and this was what happened to India 🇮🇳 when #DeltaVariant emerged & hit India hard… this is the reality when O2 runs out.
14) Because if you don’t lock down, India and UK are what you get… but Australia’s vaccination rates are closer to India than to UK. So that’s not good.
15) even if you have 46% UK vaccination rate… this is what you get in UK - 10% of all hospitalizations still among those 2 dose vaccinated that offers 79-88% protection via Pfizer and 60% protection via AZ… 94% protection against vaccination. Still #DeltaVariant breakthroughs.
16) Local NSW health minister laments the lack of vaccine supplies - an “ongoing issue”…. Australia govt should have ordered more faster. If even non-wealthy South American countries can order millions, so can Australia 🇦🇺. Cmon
17) Apparently Australia 🇦🇺 just finally waking up that the virus is airborne. Perspex (plexiglass) screens are ineffective against airborne transmission it’s suddenly dawning on them finally 17 months after Wuhan. #COVIDisAirborne ht @DamianTheAussie
18) I’m seeing apologist comments like “AUS ordered 195 million doses… it’s the manufacturers who are late” ➡️ Nope, sorry—It’s now June 2021. Every major wealthy country has plentiful vaccines. Even many poorer LMIC countries have half their country 1 shot vaccinated (eg Chile)
19) Ummm… AUS is at just **5.68% two dose vaccinated**… that’s barely more than India… and 🇮🇳 ran out of oxygen for the country when #DeltaVariant slammed it hard. AUS is in deep trouble if this lockdown don’t stop Delta fast.
20) Dear @ScottMorrisonMP, Australia 🇦🇺’s vaccination rate is abysmal… your slow vaccine acquisition & rollout has jeopardized your county. The current vaccination level is not enough to stop #DeltaVariant without sharper lockdowns and faster action with masks & ventilation. 🙏
21) Further embarrassing — healthcare workers in Australia 🇦🇺 still only use mere surgical masks instead of formal high grade N95 masks in hospitals. Not even KN95 or FFP2 premium masks. This is shamefully inadequate HCW protection for an airborne virus. AUS need to switch ASAP.
📍 THE 17 FIRED MEMBERS OF CDC’s VACCINE ADVISORY COMMITTEE (ACIP) speak out…
📍“As former ACIP members, we are deeply concerned that these destabilizing decisions, made without clear rationale, may roll back the achievements of US immunization policy, impact people’s access to lifesaving vaccines, and ultimately put US families at risk of dangerous and preventable illnesses.” 🔥
Full text:
Vaccines are one of the greatest global public health achievements. Vaccine recommendations have been critical to the global eradication of smallpox and the elimination of polio, measles, rubella, and congenital rubella syndrome in the US. They have also dramatically decreased cases of hepatitis, meningitis, mumps, pertussis (whooping cough), pneumonia, tetanus, and varicella (chickenpox), and prevented cancers caused by hepatitis B virus and human papillomaviruses.1 Recent scientific advancements enabled the accelerated development, production, and evaluation of COVID-19 vaccines, leveraging novel technologies that are estimated to have prevented approximately 1.6 million hospitalizations and 235 000 deaths in the US alone.2
For more than 60 years, the Advisory Committee on Immunization Practices (ACIP)—codified in the federal regulations (42 USC 217a: advisory councils or committees)—has served as a panel of experts that reviews the most up-to-date evidence on vaccines and monoclonal antibodies (eg, against respiratory syncytial virus [RSV]), providing sound recommendations to the US Centers for Disease Control and Prevention (CDC) regarding how vaccines should be used. ACIP recommendations are the cornerstone of the immunization program in this country. First, they serve as guidance and are the national standard for the use of Food and Drug Administration (FDA) authorized and licensed vaccines, providing a unified and trusted approach to vaccinations for the diverse array of immunization providers across the US. Second, they ensure science-based and tested immunization schedules that are optimized for well-timed protection against serious diseases. Third, the recommendations affect insurance coverage and safeguard broad access for vaccines. Fourth, ACIP’s continued monitoring of disease epidemiology and scrutiny of vaccine safety inform timely updates to recommendations that have maintained the trust and protection of the population. This transparent and ongoing surveillance of vaccines is one of the most stringent around the world, historically making the deliberations and decisions of this committee a beacon for immunization programs globally, while also serving as the foundation for recommendations harmonized with leading medical organizations in the US.3,4
ACIP committee members have always been selected through a rigorous process based on their expertise in immunology, epidemiology, pediatrics, obstetrics, internal and family medicine, geriatrics, infectious diseases, and public health. Historically, committee members were chosen because they worked at hospitals, clinics, health departments, universities, and other organizations where they dedicated themselves to caring for patients, conducting research, and helping to prevent and treat infectious diseases. Members’ deep understanding of immunization issues ensured that vaccine policies were grounded in scientific evidence, aligned with the needs of economically, socially, and medically diverse US communities, and always considered the public value, trust, and acceptability of vaccines.
Despite recent suggestions to the contrary, health care providers and the US public trust ACIP. For the past 18 years, the National Immunization Survey has shown that 99 of every 100 children in the US have received at least some recommended vaccines by 2 years of age, consistent with acceptance of ACIP recommendations implemented by trusted clinicians (National Immunization Survey - Childof Healthy People 2030).…
2) Full text part 2:
This does not suggest the population is so distrustful that it warrants dismantling the process by which vaccines have been recommended. ACIP standard procedures have minimized the risk of alleged conflicts of interest and biases. For decades, members of ACIP have undergone a thorough application and review process to participate. Proposed members submitted letters of support from other known experts and peers, completed an interview process, underwent a background check, and disclosed financial interests that might be considered a conflict, including any professional or financial relationships of immediate family members. Historically, it has taken up to 2 years for nominees to be approved to join ACIP.
Once part of the committee, ACIP members spent significant time preparing for meetings, reviewing the scientific evidence, and chairing work groups that, along with many CDC public health officials, led to the final recommendations that were determined during public meetings, which also included opportunities for public comment. Recordings of these meetings, agendas, and presentations were publicly available. Additionally, members agreed to ongoing monitoring and disclosure throughout their tenure. For example, potential conflicts of interest were reviewed throughout their time on the committee. Statements about potential conflicts were required during each meeting and before each vote, and members recused themselves from voting if any conflicts were identified. These disclosures have also recently been posted on the CDC website for public scrutiny. ACIP was among the most stringent and transparent of the federal committees, and we hope those criteria will apply to any new members joining the committee.
The abrupt dismissal of the entire membership of the ACIP, along with its executive secretary, on June 9, 2025, the appointment of 8 new ACIP members just 2 days later, and the recent reduction of CDC staff dedicated to immunizations have left the US vaccine program critically weakened.5,6 These actions have stripped the program of the institutional knowledge and continuity that have been essential to its success over decades. Notably, the ACIP charter specifies that committee members serve overlapping terms to ensure continuity and avoid precisely the disruption that will now ensue. The termination of all members and its leadership in a single action undermines the committee’s capacity to operate effectively and efficiently, aside from raising questions about competence.
Compounding these concerns, recent changes to COVID-19 vaccine policy, made directly by the HHS secretary and released on social media, appear to have bypassed the standard, transparent, and evidence-based review process.7 Such actions reflect a troubling disregard for the scientific integrity that has historically guided US immunization strategy. The newly stated strategy to replace ACIP members with individuals who will “exercise independent judgment, refuse to serve as a rubber stamp, and foster a culture of critical inquiry” is already leading to warnings by academic and scientific institutions, professional organizations, and the public who for decades have known well that these sought-after qualities precisely characterized the now-dismissed members of the ACIP.5
3) Part 3:
As former ACIP members, we are deeply concerned that these destabilizing decisions, made without clear rationale, may roll back the achievements of US immunization policy, impact people’s access to lifesaving vaccines, and ultimately put US families at risk of dangerous and preventable illnesses. Vaccines and the anti-RSV monoclonal antibodies are lifesaving, and people in the US deserve to have recommendations and broad access to use them to prevent serious diseases. In this age of government efficiency, the US public needs to know that the routine vaccination of approximately 117 million children from 1994-2023 likely prevented around 508 million lifetime cases of illness, 32 million hospitalizations, and 1 129 000 deaths, at a net savings of $540 billion in direct costs and $2.7 trillion in societal costs.8Finally, as individuals, we remain committed to evidence-based vaccine policy, both through our ongoing work in immunization science, public health, and medical education, and by supporting future efforts to keep America healthy that uphold scientific rigor and the public’s trust.
We might soon see the Trump WH impose tariffs on pharmaceuticals—patients will suffer and die.
During the past few weeks, President Trump’s on-again, off-again tariff wars have rattled the stock market, decimated many Americans’ retirement funds, and promised to send grocery prices soaring—and his administration hasn’t even gotten to critical pharmaceutical tariffs yet. But that will likely be the next shoe to drop.
Trump exempted pharmaceuticals from his first round of tariffs in early April, but recently declared that he intends to impose “a major tariff” on imported medicines “very shortly.” These tariffs, he claims, will prompt pharmaceutical companies to leave countries including China and India and begin “opening up their plants all over the place.”
Commerce Secretary Howard Lutnick said in a television interview in mid-April that these tariffs are coming in the “next month or two.”
2) The majority of brand name drugs used in the United States are imported. Even generic drugs often rely on ingredients and direct imports from China, including pain relievers and cardiovascular drugs used by millions.
3) The United States was already facing a drug shortage crisis before Trump’s tariff announcement. Now, his policies will drive upnot only the cost of medicines, but also other health care items such as X-ray machines and medical instruments.
It’s a trap: CATCH 22—if you register, ICE will deport you. If you don’t register, you’ve now committed a crime for the first time, and ICE will deport you. Trump doesn’t care if you’ve paid all taxes and followed all laws—ICE will deport you.
2) The Department of Homeland Security announced that it was mandating that all people in the United States illegally register with the federal government, and said those who didn’t self-report could face fines or prosecution. ***Failure to register is considered a crime***
3) Registration will be mandatory for everyone 14 and older without legal status. People registering have to provide their fingerprints and address, and parents and guardians of anyone under age 14 must ensure they registered. The registration process also applies to Canadians who are in the U.S. for more than 30 days, such as so-called snowbirds who spend winter months in places like Florida.
3) “Kennedy is set to announce Thursday the planned changes, which include axing 10,000 full-time employees spread across departments tasked with responding to disease outbreaks, approving new drugs, providing insurance for the poorest Americans and more”.